Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
204 studies found for:    psoriatic arthritis | psoriatic arthritis
Show Display Options
Rank Status Study
21 Recruiting Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment (WPAI))
Condition: Psoriatic Arthritis
Intervention:
22 Completed Study of Psoriatic Arthritis
Conditions: Psoriasis;   Psoriatic Arthritis
Intervention:
23 Withdrawn Safety and Effectiveness and Effect on Quality of Life and Work Productivity of Humira in Patients With Psoriatic Arthritis in Clinical Routine
Condition: Psoriatic Arthritis
Intervention: Biological: adalimumab (Humira)
24 Unknown  Psoriatic Arthritis Treat to Target vs. Usual Care
Condition: Psoriatic Arthritis (PsA)
Intervention: Other: Intensive Care
25 Recruiting Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study
Conditions: Psoriatic Arthritis;   Psoriasis;   Impaired Glucose Tolerance;   Type 2 Diabetes
Interventions: Drug: liraglutide;   Other: Placebo
26 Completed
Has Results
Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care
Conditions: Rheumatoid Arthritis;   Psoriatic Arthritis;   Ankylosing Spondylitis
Intervention:
27 Completed Differential Clinical and Serologic Response in Psoriasis and Psoriatic Arthritis to Drug Treatment
Condition: Psoriatic Arthritis
Intervention:
28 Completed Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: 210 mg brodalumab;   Drug: 140 mg brodalumab;   Drug: Placebo
29 Completed Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Biological: AIN457A
30 Unknown  Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: Open label H.P. Acthar Gel
31 Completed Rituxan With or Without Methotrexate in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: Rituximab
32 Completed Effect of Exercise and Diet on Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Other: Diet;   Other: Exercise;   Other: Diet and Exercise;   Other: Healthy Lifestyle (Control) Group
33 Completed Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Infliximab;   Drug: Etanercept
34 Completed
Has Results
Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Biological: AIN457;   Biological: Placebo
35 Terminated Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: 210 mg brodalumab;   Drug: 140 mg brodalumab;   Drug: Placebo
36 Completed Multiple Dose Study of UCB4940 in Subjects With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: UCB4940 40 mg;   Drug: UCB4940 80 mg;   Drug: UCB4940 160 mg;   Drug: UCB4940 240 mg;   Drug: UCB4940 320 mg;   Drug: UCB4940 560 mg;   Other: Placebo
37 Completed A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: Adalimumab (HUMIRA®)
38 Completed
Has Results
Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice
Conditions: Psoriasis;   Psoriatic Arthritis
Intervention: Procedure: lab draws and imaging
39 Recruiting Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Etanercept + Oral Methotrexate;   Drug: Etanercept + Placebo for Methotrexate;   Drug: Oral Methotrexate + Placebo for Etanercept
40 Completed
Has Results
An Effectiveness and Safety Study of CNTO 1275 in Patients With Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: CNTO 1275 63 mg;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years